Cara Therapeutics
Stock Forecast, Prediction & Price Target
Cara Therapeutics Financial Estimates
Cara Therapeutics Revenue Estimates
Cara Therapeutics EBITDA Estimates
Cara Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $23.02M N/A | $41.86M 81.80% | $20.96M -49.91% | Avg: $6.79M Low: $6.79M High: $6.79M avg. -67.61% | Avg: $7.02M Low: $7.02M High: $7.02M avg. 3.41% | Avg: $17.32M Low: $17.32M High: $17.32M avg. 146.64% | Avg: $58.73M Low: $58.73M High: $58.73M avg. 239.08% |
Net Income
% change YoY
| $-88.19M N/A | $-83.41M 5.41% | $-118.51M -42.07% | Avg: $-43.86M Low: $-43.86M High: $-43.86M avg. 62.99% | Avg: $-40.39M Low: $-40.39M High: $-40.39M avg. 7.90% | Avg: $-46.35M Low: $-46.35M High: $-46.35M avg. -14.74% | Avg: $-34.43M Low: $-34.43M High: $-34.43M avg. 25.70% |
EBITDA
% change YoY
| $-89.08M N/A | $-87.53M 1.73% | $-117.65M -34.40% | Avg: $-5.37M Low: $-5.37M High: $-5.37M avg. 95.43% | Avg: $-5.55M Low: $-5.55M High: $-5.55M avg. -3.41% | Avg: $-13.71M Low: $-13.71M High: $-13.71M avg. -146.64% | Avg: $-46.49M Low: $-46.49M High: $-46.49M avg. -239.08% |
EPS
% change YoY
| -$1.74 N/A | -$1.55 10.91% | -$2.19 -41.29% | Avg: -$0.81 Low: -$0.81 High: -$0.81 avg. 63.01% | Avg: -$0.75 Low: -$0.75 High: -$0.75 avg. 7.90% | Avg: -$0.86 Low: -$0.86 High: -$0.86 avg. -14.74% | Avg: -$0.64 Low: -$0.64 High: -$0.64 avg. 25.70% |
Operating Expenses
% change YoY
| $112.11M N/A | $122.13M 8.94% | $136.28M 11.58% | Avg: $5.93M Low: $5.93M High: $5.93M avg. -95.64% | Avg: $6.14M Low: $6.14M High: $6.14M avg. 3.41% | Avg: $15.14M Low: $15.14M High: $15.14M avg. 146.64% | Avg: $51.35M Low: $51.35M High: $51.35M avg. 239.08% |
FAQ
What is Cara Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.46% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -43.86M, average is -43.86M and high is -43.86M.
What is Cara Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 80.38% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $6.79M, average is $6.79M and high is $6.79M.
What is Cara Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 20.46% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.81, average is -$0.81 and high is $-0.81.